Economic Impact Linked to the Reduction of Exacerbations When a Treatment Regime With Inhaled Antibiotics Is Switched to Aztreonam Lysine in Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused by Pseudomonas Aeruginosa
Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1659
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
Elsevier BV